Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS, M.C.P.S
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS
General Physician
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, M.R.C.P. (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, FCPS , FRCP, MRCP, M.Sc (Diabetes)
General Physician
MBBS, Diploma American Board Internal Medicine
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures